Neuroendocrine Oncologist Faculty - University of Iowa

The University of Iowa Holden Comprehensive Cancer Center and the Division of Hematology, Oncology and Blood & Marrow Transplantation are seeking a fellowship-trained BC/BE Neuroendocrine Oncologist. The successful candidate will lead and/or contribute to a robust translational state-wide research program in neuroendocrine oncology with established laboratory and clinical collaborators. This position will be at the rank of Assistant Professor, Associate Professor or Full Professor to either the tenure or clinical track (non-tenure track), depending on qualifications and experience. Appointment to the rank of Instructor (non-track) may also be considered.

The Carver College of Medicine is part of a major research university and ranks 19th among public universities in NIH research funding. The Holden Comprehensive Cancer Center is a National Cancer Institute-designated comprehensive cancer center that collaborates closely with the College and the University of Iowa Hospitals and Clinics. A particular strength of the program is a growing portfolio of investigator-initiated and phase I trials including many based-on research being conducted in University of Iowa laboratories. The hospital is one of the largest university-owned teaching hospitals in the United States and is adjacent to the Iowa City Department of Veterans Affairs Medical Center.

The Division of Hematology-Oncology and Blood & Marrow Transplantation has a broad mission, spanning benign and malignant hematology and solid tumor oncology. Division faculty lead more than 200 active clinical research trials at any given time for a wide range of cancers and blood disorders and operate Iowa’s only FACT-accredited bone marrow transplant unit. The division provides services at University of Iowa Health Care, the Iowa City VA Medical Center, and at several regional outreach sites in southeast Iowa.

Education Requirement:

• Candidates must have an MD degree or equivalent.
• Completion of an ACGME-accredited Residency Program is required.

Required Qualifications:

• Clinical experience in Neuroendocrine Oncology is required.
• Candidates will show evidence of a commitment to clinical teaching, clinical research, and patient care experience in Neuroendocrine Oncology.

Certifications:

• Must be licensed or eligible for licensure in the state of Iowa.
• Must be board certified or eligible for certification in Medical Oncology or Endocrinology.

Desirable Qualifications:

• Experience leading neuroendocrine trials in medical oncology.
• Nationally or internationally recognized clinical trial experience.
• Academic experience with extramural grants, clinical research collaborations, and/or training programs.

The University of Iowa Health System (UI Health) is a comprehensive academic medical center affiliated with the University of Iowa, encompassing UI Hospitals & Clinics, UI Stead Family Children's Hospital, and UI Roy J. and Lucille A. Carver College of Medicine. Established with a commitment to excellence in patient care, research, and education, UI Health serves as a hub for healthcare innovation in Iowa and beyond. UI Hospitals & Clinics, the flagship hospital of UI Health, is consistently ranked among the top hospitals in the United States and has been recognized as the 11th best employer for diversity in the healthcare sector, underscoring its commitment to fostering an inclusive workplace environment. We offer specialized care across a wide range of medical and surgical specialties, including cancer care, cardiology, neurology, and organ transplantation.

As Iowa's only comprehensive academic medical center, we provide advanced treatments and therapies, integrating research discoveries into patient care to improve outcomes and quality of life. Our research enterprise is led by the Carver College of Medicine, renowned for its pioneering discoveries and advancements in biomedical sciences. Faculty and researchers at the Carver College of Medicine conduct groundbreaking research in areas such as cancer biology, neuroscience, genetics, and public health. This research not only expands scientific knowledge but also translates into innovative treatments and therapies that benefit patients worldwide.